GUTS · Fractyl Health, Inc.
$0.68
+0.02 (+2.72%)
At close · Aug 14
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, these existing cash resources are not expected to be sufficient to fund the Company's current operating plan for at least twelve months from the issuance date of this Quarterly Report on Form 10-Q. As a result, substantial doubt exists about the Company's ability to continue as a going concern for at least one year after the date that these financial statements are issued.”View the 10-Q filed Aug 10, 2026
Market Cap
$108.24M
Shares
159.18M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-01-30 | JAY CAPLAN | Officer | 43,818 | 2025-01-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-01-30 | HARITH RAJAGOPALAN | Director, Officer | 111,920 | 2025-01-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-09-12 | JAY D CAPLAN | Officer | 65,000 | 2024-09-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–3 of 3 filings
Key facts
CIK
1572616
CUSIP
35168W103
13F (30d)
73 filings
73 filers
Visit website
Investor relations